Pharmacotherapy of the overactive bladder and advances in drug delivery

被引：23

作者：

Cannon, TW ^{[1
]}

Chancellor, MB ^{[1
]}

机构：

[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA

来源：

CLINICAL OBSTETRICS AND GYNECOLOGY | 2002年 / 45卷 / 01期

关键词：

D O I：

10.1097/00003081-200203000-00022

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：205 / 217

页数：13

共 37 条

[31] Genitourinary tract patent update [J].

Smith, CP ;

Chancellor, MB .

EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (01) :17-31

[32]

SZALLASI A, 1990, PAIN, V30, P571

[33]

THOR KB, 1995, J PHARMACOL EXP THER, V274, P1014

[34] Tolterodine once-daily: Superior efficacy and tolerability in the treatment of the overactive bladder [J].

Van Kerrebroeck, P ;

Kreder, K ;

Jonas, U ;

Zinner, N ;

Wein, AN .

UROLOGY, 2001, 57 (03) :414-421

[35] Pharmacologic options for the overactive bladder [J].

Wein, AJ .

UROLOGY, 1998, 51 (2A) :43-47

[36] The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results [J].

Wiart, L ;

Joseph, PA ;

Petit, H ;

Dosque, JP ;

de Seze, M ;

Brochet, B ;

Deminiere, C ;

Ferriere, JM ;

Mazaux, JM ;

N'Guyen, P ;

Barat, M .

SPINAL CORD, 1998, 36 (02) :95-99

[37]

Yu YB, 1999, J PHARMACOL EXP THER, V290, P825

← 1 2 3 4 →